• 13 March 2018

    Can tech companies disrupt American healthcare?

    In the past few weeks tech companies like Amazon, Apple and Google have announced their intentions to enter the American healthcare industry, in an attempt to reduce ever-increasing healthcare costs...

  • 8 March 2018

    Should we change how we think about diabetes?

    The push for a more personalized approach to diabetes management has been reenergized by recent research that suggests solely classifying diabetes into type 1 or type 2 diabetes (T1D, T2D)...

  • 28 February 2018

    Shire, Microsoft and EURORDIS form a strategic alliance

    Shire, a global biotechnology company focused on rare diseases, has formed a strategic alliance with Microsoft, a well-known technology company, and the European Organisation for Rare Diseases (EURORDIS)–Rare Diseases Europe,...

  • 27 February 2018

    UK tops European markets for diagnosis of early-stage CKD

    Chronic kidney disease (CKD) is a significant cause of morbidity and diminished quality of life for individuals with the disease. GlobalData epidemiologists analysed CKD epidemiology trends and found that the...

  • 15 February 2018

    What is driving the high flu rates in Texas?

    The current 2017–2018 influenza season is rivalling the historical H1N1 pandemic of 2009–2010, which caused a global death toll at more than 284,000 people.